Ingevity (NGVT) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
8 Dec, 2025Business overview and global presence
Operates in 75 countries with 11 manufacturing locations, 24 sites, and 7 technical centers, employing about 1,500 people globally.
Headquartered in North Charleston, SC, with facilities in the Americas, Europe, and Asia.
54% of net sales are from North America, 27% from Asia-Pacific, 14% from EMEA, and 4% from South America.
2024 revenue reached $1.2 billion, with an adjusted EBITDA margin of 31.4%.
Free cash flow for 2024 was $51.0 million, and cash flow from operations was $128.6 million.
Business segments and financial performance
Three main segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals.
Performance Materials: $609.6M sales, $319.1M EBITDA, 52.3% margin, focused on activated carbon for auto emission control and purification.
Advanced Polymer Technologies: $188.6M sales, $35.2M EBITDA, 18.7% margin, specializing in caprolactone-based polymers for bioplastics and industrial uses.
Performance Chemicals: $401.9M sales, $46.5M EBITDA, 11.6% margin, with products for road construction, preservation, and marking.
Product innovation and sustainability
Activated carbon products save over 8 million gallons of gasoline daily by capturing and reusing vapors in vehicles.
Capa® caprolactone thermoplastics are certified biodegradable in multiple environments, supporting circular economy goals.
Evotherm® warm mix asphalt reduces paving temperatures by 50°F, cuts energy use by at least 20%, and lowers CO2 emissions by 30%.
73% of raw materials used are renewable, and 53% of products by revenue align with UN Sustainable Development Goals.
ISCC PLUS mass balance accreditation and eight biodegradation certifications for Capa® products.
Latest events from Ingevity
- Strategic transformation, board refreshment, and strong financial and ESG performance drive key proposals.NGVT
Proxy Filing17 Mar 2026 - Board recommends approval of all proposals, including director elections and incentive plan changes.NGVT
Proxy Filing17 Mar 2026 - Adjusted EBITDA margin rose to 31.9%, free cash flow reached $274M, and leverage improved to 2.6x.NGVT
Q4 202526 Feb 2026 - Q2 net loss of $283.7M on $390.6M sales, with major goodwill impairment and restructuring.NGVT
Q2 20242 Feb 2026 - Q3 2024 net sales fell 16% and net loss was $107.2M, but guidance was reaffirmed.NGVT
Q3 202417 Jan 2026 - Record Performance Materials results and strong cash flow drive improved 2025 outlook.NGVT
Q4 202426 Dec 2025 - Sharpened focus on core segments, divestitures, and strong cash returns drive growth and value.NGVT
Investor Update15 Dec 2025 - Record financial results, board refreshment, and key votes amid a contested director election.NGVT
Proxy Filing1 Dec 2025 - Leadership overhaul, portfolio optimization, and strong governance drive 2024 transformation.NGVT
Proxy Filing1 Dec 2025